Table 3 Respiratory and haematological dysfunction, ICU monitoring and treatment
From: Characteristics and outcomes of cancer patients in European ICUs
| Â | No cancer (n = 2674) | Solid tumours (n = 404) | Haematological cancer (n = 69) |
|---|---|---|---|
Mechanical ventilation | 1724 (64.5%) | 253 (62.6%) | 48 (69.6%) |
ALI/ARDS | 325 (12.2%) | 47 (11.6%) | 21 (30.4%)$ |
PaO 2 /FiO 2 | 202.8 (133.4 to 295.0) | 224.0 (144.0 to 324.3) | 140.0 (94.0 to 206.2)$ |
MV, days/patient | 3.0 (1.0 to 7.0) | 2.0 (1.0 to 6.0) | 4.0 (2.0 to 6.0) |
Leucopenia | 43 (1.6%) | 14 (3.5%)* | 17 (24.6%)$ |
Thrombocytopenia | 373 (13.9%) | 52 (12.9%) | 35 (50.7%)$ |
Pulmonary artery catheter | 430 (16.1%) | 37 (9.2%)$ | 14 (20.3%) |
Central venous catheter | 1896 (70.9%) | 317 (78.5%) | 59 (85.5%) |
Arterial catheter | 1882 (70.4%) | 304 (75.2%) | 54 (78.3%)$ |
Vasopressors | 1089 (40.7%) | 163 (40.3%) | 41 (59.4%)* |
Inotropes | 505 (18.9%) | 61 (15.1%) | 20 (29.0%)* |
Haemofiltration | 184 (6.9%) | 16 (4.0%) | 11 (15.9%)* |
Haemodialysis | 121 (4.5%) | 16 (4.0%) | 4 (5.8%) |